. "Over 99%, predominantly to serum albumin."@en . "Tamibarotene"@en . . . . . "94497-51-5"@en . "Tamibarotene is a novel synthetic retinoid for acute promyelocytic leukaemia (APL). Tamibarotene is currently approved in Japan for treatment of recurrent APL, and is undergoing clinical trials in the United States."@en . . "Amnoid"@en . "approved"@en . . . . "Tamibaro"@en . . . "Tamibarotene"@en . . . . . "Am 80"@en . . . "Hisao Ekimoto, \"TAMIBAROTENE CAPSULE PREPARATION.\" U.S. Patent US20100048708, issued February 25, 2010."@en . . "retinobenzoic acid"@en . . "investigational"@en . . " "@en . "Humans and other mammals"@en . . . . "# Miwako I, Kagechika H: Tamibarotene. Drugs Today (Barc). 2007 Aug;43(8):563-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17925887 # Tamibarotene: AM 80, retinobenzoic acid, Tamibaro. Drugs R D. 2004;5(6):359-62. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15563242 # Sanda T, Kuwano T, Nakao S, Iida S, Ishida T, Komatsu H, Shudo K, Kuwano M, Ono M, Ueda R: Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis. Leukemia. 2005 Jun;19(6):901-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15843826 # Takeuchi M: [Clinical experience with a new synthetic retinoid, tamibarotene (Am-80) for relapsed or refractory acute promyelocytic leukemia] Gan To Kagaku Ryoho. 2006 Mar;33(3):397-401. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16531727 # Mizojiri K, Okabe H, Sugeno K, Misaki A, Ito M, Kominami G, Esumi Y, Takaichi M, Harada T, Seki H, Inaba A: Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man. Arzneimittelforschung. 1997 Mar;47(3):259-69. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9105544"@en . . . "Tamibarotene is a specific agonist for retinoic acid receptor alpha/beta with possible binding to retinoid X receptors (RXR)."@en . . . . . "Investigated for use/treatment in leukemia (unspecified)."@en . . . . . . . . . . . . .